{
    "nctId": "NCT00804128",
    "briefTitle": "Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)",
    "officialTitle": "Contrast-enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 76,
    "primaryOutcomeMeasure": "Comparison of ductal carcinoma in situ (DCIS)-optimized MRI quality",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Meets 1 of the following criteria:\n\n  * Patients at the University of California, San Francisco Breast Care Center meeting the following criteria:\n\n    * Biopsy proven ductal carcinoma in situ (DCIS) of the breast.\n    * Has undergone mammography within the past 60 days.\n    * ADH patients: over 18, no prior history of breast disease.\n\nPATIENT CHARACTERISTICS:\n\n* Referrals to this trial are through breast care clinicians only\n* Not pregnant or nursing (or stopped nursing within the past 3 months)\n* Negative pregnancy test\n* No contraindication to MRI (e.g., implanted pacemaker, implanted ferromagnetic device, ferromagnetic aneurysm clip, severe claustrophobia, ocular metal fragments, or shrapnel injury)\n\nPRIOR CONCURRENT THERAPY:\n\n* More than 2 years since prior surgery to the ipsilateral breast (patient)\n* No prior radiotherapy to the ipsilateral breast (patient)\n* No prior cytotoxic regimens (patient)",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}